Guangna Liu
- Oncology top 10%
- Immunology top 10%
- Biomedical Engineering
- Molecular Biology
- Genetics
- Topics
- CAR-T cell therapy research (6 papers)Immune Cell Function and Interaction (4 papers)Immunotherapy and Immune Responses (3 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Guangna Liu
11 papers receiving 653 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 453
- Immunology 277
- Biomedical Engineering 217
- Molecular Biology 207
- Genetics 118
Countries citing papers authored by Guangna Liu
This map shows the geographic impact of Guangna Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangna Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangna Liu more than expected).
Fields of papers citing papers by Guangna Liu
This network shows the impact of papers produced by Guangna Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangna Liu. The network helps show where Guangna Liu may publish in the future.
Co-authorship network of co-authors of Guangna Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Guangna Liu. A scholar is included among the top collaborators of Guangna Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangna Liu. Guangna Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | Bacteria-derived nanovesicles enhance tumour vaccination by trained immunitybreakdown → | 101 |
| 3 | 12 | |
| 4 | 12 | |
| 5 | 27 | |
| 6 | 113 | |
| 7 | 161 | |
| 8 | 3 | |
| 9 | 158 | |
| 10 | 40 | |
| 11 | 19 |
About Guangna Liu
Guangna Liu is a scholar working on Immunology, Oncology and Obstetrics and Gynecology, having authored 11 papers that have together received 659 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (453 citations), Immunology (277 citations) and Biomedical Engineering (217 citations). Guangna Liu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Xin Lin, Xueqiang Zhao, Wei Rui, Daosheng Huang, Hongli Zheng, Yuewei Zhang, Fei Yu, Jiahong Dong, Lemei Jia and Song Lin. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.